EUVIMEDEUVIMED entdecken
Crossref

A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma

Angela Chou, Min Ru Qiu, Henry Crayton, Bin Wang, Mahsa S Ahadi, John Turchini, Adele Clarkson, Loretta Sioson, Amy Sheen, Nisha Singh, Roderick J Clifton-Bligh, Bruce G Robinson und 14 weitere

Modern Pathology · 2023

DOI: 10.1016/j.modpat.2023.100329 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2023. Verfasst von Angela Chou und 25 weiteren Autor:innen. Beteiligte Einrichtung: NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, New South Wales, Australia; Faculty of Medicine an…. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Carcinoma, Papillary, Lung Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Cancer Institute NSW.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diffuse sclerosing variant papillary thyroid carcinoma (DS-PTC) is characterized clinically by a predilection for children and young adults, bulky neck nodes, and pulmonary metastases. Previous studies have suggested infrequent BRAFV600E mutation but common RET gene rearrangements. Using strict criteria, we studied 43 DS-PTCs (1.9% of unselected PTCs in our unit). Seventy-nine percent harbored pathogenic gene rearrangements involving RET, NTRK3, NTRK1, ALK, or BRAF; with the remainder driven by BRAFV600E mutations. All 10 pediatric cases were all gene rearranged (P = .02). Compared with BRAFV600E-mutated tumors, gene rearrangement was characterized by psammoma bodies involving the entire lobe (P = .038), follicular predominant or mixed follicular architecture (P = .003), pulmonary metastases (24% vs none, P = .04), and absent classical, so-called "BRAF-like" atypia (P = .014). There was no correlation between the presence of gene rearrangement and recurrence-free survival. Features associated with persistent/recurrent disease included pediatric population (P = .030), gene-rearranged tumors (P = .020), microscopic extrathyroidal extension (P = .009), metastases at presentation (P = .007), and stage II disease (P = .015). We conclude that DS-PTC represents 1.9% of papillary thyroid carcinomas and that actionable gene rearrangements are extremely common in DS-PTC. DS-PTC can be divided into 2 distinct molecular subtypes and all BRAFV600E-negative tumors (1.5% of papillary thyroid carcinomas) are driven by potentially actionable oncogenic fusions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsCarcinoma, PapillaryLung NeoplasmsYoung AdultHumansChildThyroid Cancer, PapillaryProto-Oncogene Proteins B-rafMutationReceptor Protein-Tyrosine Kinases

Stichwörter der Autor:innen

ALKBRAFNTRKRETdiffuse sclerosinggene fusionspapillary thyroid carcinoma

Substanzen

Proto-Oncogene Proteins B-rafReceptor Protein-Tyrosine Kinases

Autor:innen und Institutionen

  • NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, New South Wales, Australia; Faculty of Medicine and Health Sciences and Northern Clinical School, University of Sydney,…
  • Department of Anatomical Pathology, SydPATH, St Vincent's Hospital, Darlinghurst, New South Wales, Australia; University of NSW, Randwick, New South Wales, Australia.
  • Faculty of Medicine and Health Sciences and Northern Clinical School, University of Sydney, Sydney, New South Wales, Australia.
  • Department of Anatomical Pathology, SydPATH, St Vincent's Hospital, Darlinghurst, New South Wales, Australia.
  • Department of Anatomical Pathology, Douglass Hanly Moir Pathology (A Sonic Healthcare Practice), Macquarie Park, New South Wales, Australia; Discipline of Pathology, Macquarie Medical School, Macquarie University, New S…
  • NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, St Leonards, New South Wales, Australia; Cancer Diagnosis and Pathology Research Group, Kolling Institute of Medical Research, St Leo…

Förderung

  • Cancer Institute NSW

Zitieren

APA

Chou, A., Qiu, M. R., Crayton, H., Wang, B., Ahadi, M. S., Turchini, J., Clarkson, A., Sioson, L., Sheen, A., Singh, N., Clifton-Bligh, R. J., Robinson, B. G., Gild, M. L., Tsang, V., Leong, D., Sidhu, S. B., Sywak, M., Delbridge, L., Aniss, A., …, & Gill, A. J. (2023). A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma. Modern Pathology. https://doi.org/10.1016/j.modpat.2023.100329

Vancouver

Chou A, Qiu MR, Crayton H, Wang B, Ahadi MS, Turchini J, et al. A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma. Modern Pathology. 2023. doi:10.1016/j.modpat.2023.100329

BibTeX
@article{Chou2023,
  author = {Chou, Angela and Qiu, Min Ru and Crayton, Henry and Wang, Bin and Ahadi, Mahsa S and Turchini, John and Clarkson, Adele and Sioson, Loretta and Sheen, Amy and Singh, Nisha and Clifton-Bligh, Roderick J and Robinson, Bruce G and Gild, Matti L and Tsang, Venessa and Leong, David and Sidhu, Stanley B and Sywak, Mark and Delbridge, Leigh and Aniss, Ahmad and Wright, Dale and Graf, Nicole and Kumar, Amit and Rathi, Vivek and Benitez-Aguirre, Paul and Glover, Anthony R and Gill, Anthony J},
  title = {A Detailed Histologic and Molecular Assessment of the Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma},
  journal = {Modern Pathology},
  year = {2023},
  doi = {10.1016/j.modpat.2023.100329}
}
Kostenlos starten →